201 related articles for article (PubMed ID: 9162878)
21. Does size matter? Tumor size and morphology as predictors of nodal status and recurrence in endometrial cancer.
Shah C; Johnson EB; Everett E; Tamimi H; Greer B; Swisher E; Goff B
Gynecol Oncol; 2005 Dec; 99(3):564-70. PubMed ID: 16246402
[TBL] [Abstract][Full Text] [Related]
22. [Prognostic factors of cancer of the endometrium and therapeutic implications].
Michel G; Morice P; Castaigne D; Lanoux P; Pautier P; Lhommé C; Gerbaulet A; Duvillard P
Contracept Fertil Sex; 1998 Jun; 26(6):452-6. PubMed ID: 9691524
[TBL] [Abstract][Full Text] [Related]
23. [Analysis of failed management of endometrial carcinoma].
Zalutskiĭ IV; Litvinova TM
Vopr Onkol; 2006; 52(2):179-82. PubMed ID: 17195644
[TBL] [Abstract][Full Text] [Related]
24. The outcome of stage I-II clinically and surgically staged papillary serous and clear cell endometrial cancers when compared with endometrioid carcinoma.
Cirisano FD; Robboy SJ; Dodge RK; Bentley RC; Krigman HR; Synan IS; Soper JT; Clarke-Pearson DL
Gynecol Oncol; 2000 Apr; 77(1):55-65. PubMed ID: 10739691
[TBL] [Abstract][Full Text] [Related]
25. Does surgical staging of clinical Stage I endometrial carcinoma significantly alter adjuvant management?
Burke C; Hickey K
J Obstet Gynaecol; 2004 Apr; 24(3):289-91. PubMed ID: 15203630
[TBL] [Abstract][Full Text] [Related]
26. Adjuvant therapy for patients with stage I papillary serous endometrial cancer.
Alobaid A; Bruchim I; Verkooijen H; Gauthier P; Petignat P
Eur J Surg Oncol; 2006 Apr; 32(3):358-62. PubMed ID: 16414233
[TBL] [Abstract][Full Text] [Related]
27. Survival after multimodality treatment for stage IIIC endometrial cancer.
Katz LA; Andrews SJ; Fanning J
Am J Obstet Gynecol; 2001 May; 184(6):1071-3. PubMed ID: 11349160
[TBL] [Abstract][Full Text] [Related]
28. Recurrent endometrial cancer.
Del Carmen MG; Boruta DM; Schorge JO
Clin Obstet Gynecol; 2011 Jun; 54(2):266-77. PubMed ID: 21508696
[TBL] [Abstract][Full Text] [Related]
29. Early stage endometrial carcinoma--a study of management and outcome.
Burke C; Foley M; Lenehan P; Kelehan P; Flannelly G
Ir Med J; 2007; 100(10):621-3. PubMed ID: 18277731
[TBL] [Abstract][Full Text] [Related]
30. Surgical staging for patients presenting with grade 1 endometrial carcinoma.
Ben-Shachar I; Pavelka J; Cohn DE; Copeland LJ; Ramirez N; Manolitsas T; Fowler JM
Obstet Gynecol; 2005 Mar; 105(3):487-93. PubMed ID: 15738013
[TBL] [Abstract][Full Text] [Related]
31. Cost-effectiveness analysis of strategies for the surgical management of grade 1 endometrial adenocarcinoma.
Cohn DE; Huh WK; Fowler JM; Straughn JM
Obstet Gynecol; 2007 Jun; 109(6):1388-95. PubMed ID: 17540812
[TBL] [Abstract][Full Text] [Related]
32. Positive adnexal or uterine serosal involvement in stage IIIC endometrial cancer is an adverse factor for recurrence.
Hétu V; Petignat P; Wu Y; Drouin P; Sauthier P; Provencher D; Gauthier P
Gynecol Obstet Invest; 2009; 67(3):173-7. PubMed ID: 19088481
[TBL] [Abstract][Full Text] [Related]
33. [Clinical characteristics and multivariate analysis of prognostic factors in recurrent laryngeal carcinoma].
Chen YF; Chen FJ; Yang AK; Zeng ZY; Song M; Li QL
Ai Zheng; 2004 May; 23(5):584-8. PubMed ID: 15142460
[TBL] [Abstract][Full Text] [Related]
34. Posttreatment TNM staging is a prognostic indicator of survival and recurrence in tethered or fixed rectal carcinoma after preoperative chemotherapy and radiotherapy.
Chan AK; Wong A; Jenken D; Heine J; Buie D; Johnson D
Int J Radiat Oncol Biol Phys; 2005 Mar; 61(3):665-77. PubMed ID: 15708244
[TBL] [Abstract][Full Text] [Related]
35. Stage III endometrial cancer: analysis of prognostic factors and failure patterns after adjuvant chemotherapy.
Aoki Y; Kase H; Watanabe M; Sato T; Kurata H; Tanaka K
Gynecol Oncol; 2001 Oct; 83(1):1-5. PubMed ID: 11585406
[TBL] [Abstract][Full Text] [Related]
36. [Standards, options, and recommendations for the radiotherapy of patients with endometrial cancer. FNCLCC (National Federation of Cancer Campaign Centers) and CRLCC (Regional Cancer Campaign Centers)].
Thomas L; Bataillard A; Brémond A; Fondrinier E; Fervers B; Achard JL; Lansac J; Bailly C; Hoffstetter S; Basuyau JP; d'Anjou J; Descamps P; Farsi F; Guastalla JP; Laffargue F; Rodier JF; Vincent P; Pigneux J
Cancer Radiother; 2001 Apr; 5(2):163-92. PubMed ID: 11355582
[TBL] [Abstract][Full Text] [Related]
37. [The comparison of clinical and surgical-pathological staging for endometrial carcinoma].
Peng Z; Liu X; Zhang J
Zhonghua Fu Chan Ke Za Zhi; 1997 Oct; 32(10):597-600. PubMed ID: 9642375
[TBL] [Abstract][Full Text] [Related]
38. Management and outcome of recurrent well-differentiated thyroid carcinoma.
Palme CE; Waseem Z; Raza SN; Eski S; Walfish P; Freeman JL
Arch Otolaryngol Head Neck Surg; 2004 Jul; 130(7):819-24. PubMed ID: 15262757
[TBL] [Abstract][Full Text] [Related]
39. Treatment of maxillary sinus carcinoma: a comparison of the 1997 and 1977 American Joint Committee on cancer staging systems.
Le QT; Fu KK; Kaplan M; Terris DJ; Fee WE; Goffinet DR
Cancer; 1999 Nov; 86(9):1700-11. PubMed ID: 10547542
[TBL] [Abstract][Full Text] [Related]
40. The prognostic factors for patients with early cervical cancer treated by radical hysterectomy and postoperative radiotherapy.
Tsai CS; Lai CH; Wang CC; Chang JT; Chang TC; Tseng CJ; Hong JH
Gynecol Oncol; 1999 Dec; 75(3):328-33. PubMed ID: 10600284
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
